Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Ophthalmology and Therapy
|
August 1, 2024
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, et al.
Ophthalmology
|
November 9, 2007
Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome
Arghavan Almony, Matthew A Thomas, Neal H Atebara, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 19, 2014
Clinical monitoring of patients with age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab
Szilárd Kiss, Ying Liu, Joseph Brown, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 12, 2014
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Szilárd Kiss, Ying Liu, Joseph Brown, et al.
Investigative Ophthalmology & Visual Science
|
December 24, 2003
Importance of vitreous liquefaction in age-related cataract
George J Harocopos, Ying-Bo Shui, Megan McKinnon, et al.
American Journal of Ophthalmology
|
July 21, 2021
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration
Nancy M Holekamp, Srinivas Sadda, David Sarraf, et al.
American Journal of Ophthalmology
|
January 7, 2014
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration
Nancy M Holekamp, Ying Liu, Wei-Shi Yeh, et al.
American Journal of Ophthalmology
|
April 24, 2018
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, et al.
The British Journal of Ophthalmology
|
May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
Sam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.
Ophthalmology and Therapy
|
November 14, 2025
Establishing Expert Consensus on a Unified Decision Framework for Retina Patient Care
Javier Zarranz-Ventura, Aude Ambresin, Andrew Chang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Ophthalmology and Therapy
|
August 1, 2024
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants
Nancy M Holekamp, Manejeh Yaqub, Shrirang V Ranade, et al.
Ophthalmology
|
November 9, 2007
Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome
Arghavan Almony, Matthew A Thomas, Neal H Atebara, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
July 19, 2014
Clinical monitoring of patients with age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab
Szilárd Kiss, Ying Liu, Joseph Brown, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 12, 2014
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
Szilárd Kiss, Ying Liu, Joseph Brown, et al.
Investigative Ophthalmology & Visual Science
|
December 24, 2003
Importance of vitreous liquefaction in age-related cataract
George J Harocopos, Ying-Bo Shui, Megan McKinnon, et al.
American Journal of Ophthalmology
|
July 21, 2021
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration
Nancy M Holekamp, Srinivas Sadda, David Sarraf, et al.
American Journal of Ophthalmology
|
January 7, 2014
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration
Nancy M Holekamp, Ying Liu, Wei-Shi Yeh, et al.
American Journal of Ophthalmology
|
April 24, 2018
Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, et al.
The British Journal of Ophthalmology
|
May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
Sam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.
Ophthalmology and Therapy
|
November 14, 2025
Establishing Expert Consensus on a Unified Decision Framework for Retina Patient Care
Javier Zarranz-Ventura, Aude Ambresin, Andrew Chang, et al.
Page
of 7